Combix is exclusive distributor of HeiQ Medica Products to pharmacies in Spain

HeiQ Medica and Laboratorios Combix have signed an agreement that gives Combix the exclusive right to distribute HeiQ Medica made-in-EU products to all pharmacies in Spain. Combix has a nationwide marketing and sales network, and with its sales forces of 50+ representatives and other resources, it will  promote and distribute the full range of HeiQ Medica products to the 22’000 Spanish pharmacies. Products such as FFP2 masks, reusable masks, EU-made surgical type IIR masks and gowns will be HeiQ Medica and Combix co-branded and will be available exclusively at pharmacies throughout Spain.

Pedro Herranz, CEO of HeiQ Medica said: “Since the establishment of HeiQ Medica, we have been inspired by the innovative spirit of HeiQ and have been growing from strength to strength. Our latest collaboration agreement appointing Combix as the first company to exclusively distribute our 100% European made innovations in Spain is one such example and I am truly looking forward to working with them and making our quality products accessible for people in pharmacies across the country.”

HeiQ Medica’s Product Range – all powered by HeiQ Viroblock

  • Type IIR masks with HeiQ Viroblock: 100% European made and polyester base material with unique mechanical filtration properties that ensure prolonged high efficiency performance (full day wearing). Produced in a white room under the highest hygiene and quality standards.
  • FFP2 masks with HeiQ Viroblock:  CE certified and suitable as personal protective equipment (PPE) provide the best fit and protection to consumers.
  • Washable, reusable masks (up to 30 washes): High performance thanks to new HeiQ PermaX medical grade polyester filters. Available in various sizes and for different age groups with optional HeiQ technologies:
    • HeiQ Smart Temp for cooling temperature regulation (inner layer)
    • HeiQ Eco Dry for ecological durable water repellency (outer layer)
    • HeiQ Pure odor inhibitor for lasting freshness (outer layer)

Swiss Technology Award 2020 Winning HeiQ Viroblock

HeiQ Viroblock turns any fabric antiviral. It’s one of the first textile technology in the world to be proven effective against SARS-CoV-2 (COVID-19)*. HeiQ Viroblock consists of a combination of HeiQ’s patent-pending vesicle and silver technologies. The two mechanisms of attack result in minutes 100% destruction of viruses and bacteria that is unrivaled in the industry. Safe and sustainable, HeiQ Viroblock is made of 100% cosmetic grade ingredients.

Juan Luis Fernandez Balaguer, CEO of Combix is happy to seize this opportunity as exclusive distributor, saying: “We share so many values and ethical ideals with HeiQ Medica and given the synergy between their high-quality PPE products and our sales competence I am confident that we will make a serious impact on improving the lives of Spanish people as we drive these excellent technologies to market.”

Visit the HeiQ Medica website and shop for more information.

* M.J. (2020) Report on “Viral Stability and Persistence of SARS-CoV-2 on Treated Material”. Doherty Institute for Infection and Immunity, Australia

About HeiQ Medica

HeiQ Medica is a division of materials innovation conglomerate HeiQ Group with the vision to revolutionize medical devices, offering maximum protection and comfort by adding extra functionality and using innovative materials. Founded in 2020 as a joint venture between MasFabEs SL, Spain, and HeiQ Materials AG, Switzerland, HeiQ Medica serves as the innovation hub and R&D center for HeiQ to pursue its vision to apply material science & innovations to medical devices. HeiQ Medica is committed to innovation, scientific research and the manufacture of the highest quality made-in-EU personal protection equipment (PPE), medical and non-sanitary products in line with environmental, ethical and social standards. With a production capacity of 600,000 surgical masks per day and 500,000 surgical gowns a month, HeiQ Medica offers smart and fresh value propositions and a wide range of products for both the public and private sectors in Europe.

About Combix

Laboratorios Combix is a pharmaceutical company dedicated to the commercialization of generic and OTC drugs, medical devices, self-care health products, food supplements, cosmetics and personal protective equipment. The company was found in 2007 in Spain and it was acquired by the multinational Zydus Cadila. Currently, Laboratorios Combix has a portfolio of more than 200 generic drug lines (belonging to the main therapeutic areas), which have allowed them to reach a turnover of 20 million euros.


HeiQ Medica SL
Plaza de la Estación s/n
29560 Pizarra (Málaga)


+34951 743 100

Media contact for interview or high-res image:

Hoi Kwan Lam – Chief Marketing Officer –

Urbanización las Cabañas

Calle Badajoz, 2

28223 Pozuelo de Alarcón (Madrid)


++34 914 90 31 53

Media contact for interview or high-res image:

Carmen Vara – Marketing Manager –


Über die HeiQ Materials AG

Founded in 2005 as a spin-off from the Swiss Federal Institute of Technology Zurich (ETH), HeiQ is a leader in textile innovation creating some of the most effective, durable and high-performance textile technologies on the market today. HeiQ’s mission is to improve the lives of billions of people by perfecting an everyday product: Textiles. Combining three areas of expertise – scientific research, specialty materials manufacturing and consumer ingredient branding – HeiQ is the ideal innovation partner to create differentiating and sustainable textile products and capture the added value at the point of sale. With a total capacity of 35’000 tons per year HeiQ manufactures in the USA, Switzerland and Australia supplying its specialty chemical products in over 60 countries worldwide.

Firmenkontakt und Herausgeber der Meldung:

HeiQ Materials AG
Ruetistrasse 12
CH8952 Schlieren
Telefon: +41 (56) 2506850
Telefax: +41 (56) 2506841

Hoi Kwan Lam
Telefon: +41 (56) 2506850
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.